A Randomised Trial to Assess the Effectiveness of Pre-treatment With Ondansetron at Reducing Nausea and Vomiting in Patients Treated With Either the Conventional Regimen or a Modified Regimen of Acetylcysteine for Paracetamol Poisoning.

Trial Profile

A Randomised Trial to Assess the Effectiveness of Pre-treatment With Ondansetron at Reducing Nausea and Vomiting in Patients Treated With Either the Conventional Regimen or a Modified Regimen of Acetylcysteine for Paracetamol Poisoning.

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Jan 2014

At a glance

  • Drugs Acetylcysteine (Primary) ; Ondansetron (Primary)
  • Indications Nausea and vomiting
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms SNAP
  • Most Recent Events

    • 28 Nov 2013 Results published in the Lancet.
    • 19 Jan 2013 Accrual to date is 88% according to United Kingdom Clinical Research Network.
    • 19 Dec 2012 Accrual to date is 86% according to United Kingdom Clinical Research Network.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top